Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Millendo Therapeutics stock

Own Millendo Therapeutics stock in just a few minutes.

Millendo Therapeutics, Inc is a biotechnology business based in the US. Millendo Therapeutics shares (MLND) are listed on the NASDAQ and all prices are listed in US Dollars. Millendo Therapeutics employs 12 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Millendo Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MLND – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Millendo Therapeutics share price

Use our graph to track the performance of MLND stocks over time.

Millendo Therapeutics shares at a glance

Information last updated 2021-04-21.
52-week range$0.92 - $3.64
50-day moving average $1.68
200-day moving average $1.85
Wall St. target price$2.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-4.87

Buy Millendo Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Millendo Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Millendo Therapeutics financials

Gross profit TTM $0
Return on assets TTM -37.98%
Return on equity TTM -77.79%
Profit margin 0%
Book value $1.74
Market capitalisation $18.6 million

TTM: trailing 12 months

Shorting Millendo Therapeutics shares

There are currently 506,345 Millendo Therapeutics shares held short by investors – that's known as Millendo Therapeutics's "short interest". This figure is 62.5% up from 311,560 last month.

There are a few different ways that this level of interest in shorting Millendo Therapeutics shares can be evaluated.

Millendo Therapeutics's "short interest ratio" (SIR)

Millendo Therapeutics's "short interest ratio" (SIR) is the quantity of Millendo Therapeutics shares currently shorted divided by the average quantity of Millendo Therapeutics shares traded daily (recently around 1.1 million). Millendo Therapeutics's SIR currently stands at 0.46. In other words for every 100,000 Millendo Therapeutics shares traded daily on the market, roughly 460 shares are currently held short.

However Millendo Therapeutics's short interest can also be evaluated against the total number of Millendo Therapeutics shares, or, against the total number of tradable Millendo Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Millendo Therapeutics's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Millendo Therapeutics shares in existence, roughly 30 shares are currently held short) or 0.0267% of the tradable shares (for every 100,000 tradable Millendo Therapeutics shares, roughly 27 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Millendo Therapeutics.

Find out more about how you can short Millendo Therapeutics stock.

Millendo Therapeutics share dividends

We're not expecting Millendo Therapeutics to pay a dividend over the next 12 months.

Have Millendo Therapeutics's shares ever split?

Millendo Therapeutics's shares were split on a 1:15 basis on 9 December 2018. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Millendo Therapeutics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Millendo Therapeutics shares which in turn could have impacted Millendo Therapeutics's share price.

Millendo Therapeutics share price volatility

Over the last 12 months, Millendo Therapeutics's shares have ranged in value from as little as $0.9181 up to $3.64. A popular way to gauge a stock's volatility is its "beta".

MLND.US volatility(beta: 0.5)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Millendo Therapeutics's is 0.5017. This would suggest that Millendo Therapeutics's shares are less volatile than average (for this exchange).

Millendo Therapeutics overview

Millendo Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Ann Arbor, Michigan. .

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site